348
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

An integrated computational approach to screening of alkaloids inhibitors of TBX3 in breast cancer cell lines

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 3025-3041 | Received 18 Sep 2021, Accepted 15 Feb 2022, Published online: 05 Mar 2022

References

  • Abdulazeem, L., Al-Alaq, F. T., Alrubaei, H. A., Al-Mawlah, Y. H., & Alwan, W. K. (2018). Anti-cancer activity of Opuntia polyacantha alkaloid extract on human breast cancer cell line. Journal of Pharmaceutical Sciences and Research, 10(7), 1753–1754.
  • Agulnik, S. I., Garvey, N., Hancock, S., Ruvinsky, I., Chapman, D. L., Agulnik, I., Bollag, R., Papaioannou, V., & Silver, L. M. (1996). Evolution of mouse T-box genes by tandem duplication and cluster dispersion. Genetics, 144(1), 249–254. https://doi.org/10.1093/genetics/144.1.249
  • Aier, I., Varadwaj, P. K., & Raj, U. (2016). Structural insights into conformational stability of both wild-type and mutant EZH2 receptor. Scientific Reports, 6, 34984. https://doi.org/10.1038/srep34984
  • AlAjmi, M. F., Rehman, M. T., Hussain, A., & Rather, G. M. (2018). Pharmacoinformatics approach for the identification of Polo-like kinase-1 inhibitors from natural sources as anti-cancer agents. International Journal of Biological Macromolecules, 116, 173–181.
  • Al-Shabib, N. A., Khan, J. M., Malik, A., Alsenaidy, M. A., Rehman, M. T., AlAjmi, M. F., Alsenaidy, A. M., & Khan, R. H. (2018). Molecular insight into binding behavior of polyphenol (rutin) with beta lactoglobulin: Spectroscopic, molecular docking and MD simulation studies. Journal of Molecular Liquids, 269, 511–520.
  • Ameyaw, Y., & Duker-Eshun, G. (2009). The alkaloid contents of the ethno-plant organs of three antimalarial medicinal plant species in the eastern region of Ghana. International Journal of Chemical Science, 7(1), 48–58.
  • Ashkenazi, A. (2008). Targeting the extrinsic apoptosis pathway in cancer. Cytokine & Growth Factor Reviews, 19(3–4), 325–331.
  • Aubele, M., Auer, G., Braselmann, H., Nährig, J., Zitzelsberger, H., Quintanilla‐Martinez, L., Smida, J., Walch, A., Hofler, H., & Werner, M. (2002). Chromosomal imbalances are associated with metastasis‐free survival in breast cancer patients. Analytical Cellular Pathology, 24(2–3), 77–87.
  • Baldi, A. (2010). Computational approaches for drug design and discovery: An overview. Systematic Reviews in Pharmacy, 1(1), 99.
  • Bamshad, M., Le, T., Watkins, W. S., Dixon, M. E., Kramer, B. E., Roeder, A. D., Carey, J. C., Root, S., Schinzel, A., Van Maldergem, L., Gardner, R. J. M., Lin, R. C., Seidman, C. E., Seidman, J. G., Wallerstein, R., Moran, E., Sutphen, R., Campbell, C. E., & Jorde, L. B. (1999). The spectrum of mutations in TBX3: genotype/phenotype relationship in ulnar-mammary syndrome. The American Journal of Human Genetics, 64(6), 1550–1562.
  • Bamshad, M., Lin, R. C., Law, D. J., Watkins, W. S., Krakowiak, P. A., Moore, M. E., Franceschini Blanchard, P., & Brüning, E. (2015). Density functional theory of atoms and molecules. Progress in Mathematical Physics. https://doi.org/10.1007/978-3-319-14045-2_37
  • Bamshad, M., Lin, R. C., Law, D. J., Watkins, W. S., Krakowiak, P. A., Moore, M. E., Franceschini, P., Lala, R., Holmes, L. B., Gebuhr, T. C., Bruneau, B. G., Schinzel, A., Seidman, J. G., Seidman, C. E., & Jorde, L. B. (1997). Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome. Nature Genetics, 16(3), 311–315. https://doi.org/10.1038/ng0797-311
  • Binkowski, T. A., Naghibzadeh, S., & Liang, J. (2003). CASTp: computed atlas of surface topography of proteins. Nucleic Acids Research, 31(13), 3352–3355.
  • Boyd, S. C., Mijatov, B., Pupo, G. M., Tran, S. L., Gowrishankar, K., Shaw, H. M., Goding, C. R., Scolyer, R. A., Mann, G. J., Kefford, R. F., Rizos, H., & Becker, T. M. (2013). Oncogenic B-RAFV600E signaling induces the T-box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion. Journal of Investigative Dermatology, 133(5), 1269–1277.
  • Braybrook, C., Doudney, K., Marçano, A. C. B., Arnason, A., Bjornsson, A., Patton, M. A., Goodfellow, P. J., Moore, G. E., & Stanier, P. (2001). The T-box transcription factor gene TBX22 is mutated in X-linked cleft palate and ankyloglossia. Nature Genetics, 29(2), 179–183.
  • Brummelkamp, T. R., Kortlever, R. M., Lingbeek, M., Trettel, F., MacDonald, M. E., van Lohuizen, M., & Bernards, R. (2002). TBX-3, the gene mutated in Ulnar-Mammary Syndrome, is a negative regulator of p19ARF and inhibits senescence. Journal of Biological Chemistry, 277(8), 6567–6572.
  • Burgucu, D., Guney, K., Sahinturk, D., Ozbudak, I. H., Ozel, D., Ozbilim, G., & Yavuzer, U. (2012). Tbx3 represses PTEN and is over-expressed in head and neck squamous cell carcinoma. BMC Cancer, 12(1), 1–12. https://doi.org/10.1186/1471-2407-12-481
  • Carlson, H., Ota, S., Campbell, C. E., & Hurlin, P. J. (2001). A dominant repression domain in Tbx3 mediates transcriptional repression and cell immortalization: Relevance to mutations in Tbx3 that cause ulnar-mammary syndrome. Human Molecular Genetics, 10(21), 2403–2413. https://doi.org/10.1093/hmg/10.21.2403
  • Carlson, H., Ota, S., Song, Y., Chen, Y., & Hurlin, P. J. (2002). Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation. Oncogene, 21(24), 3827–3835. https://doi.org/10.1038/sj.onc.1205476
  • Chalhoub, N., & Baker, S. J. (2009). PTEN and the PI3-kinase pathway in cancer. Annual Review of Pathology: Mechanisms of Disease, 4, 127–150.
  • Cheng, H. D., Lui, Y. M., & Freimanis, R. I. (1998). A novel approach to microcalcification detection using fuzzy logic technique. IEEE Transactions on Medical Imaging, 17(3), 442–450.
  • Chin, Y. W., Balunas, M. J., Chai, H. B., & Kinghorn, A. D. (2006). Drug discovery from natural sources. The AAPS Journal, 8(2), E239–E253. https://doi.org/10.1208/aapsj080228
  • Coll, M., Seidman, J. G., & Müller, C. W. (2002). Structure of the DNA-bound T-box domain of human TBX3, a transcription factor responsible for ulnar-mammary syndrome. Structure, 10(3), 343–356.
  • Curigliano, G. (2012). New drugs for breast cancer subtypes: targeting driver pathways to overcome resistance. Cancer Treatment Reviews, 38(4), 303–310. https://doi.org/10.1016/j.ctrv.2011.06.006
  • Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/10.1038/srep42717
  • Dean, M., Fojo, T., & Bates, S. (2005). Tumour stem cells and drug resistance. Nature Reviews Cancer, 5(4), 275–284.
  • Dey, P., Kundu, A., Chakraborty, H. J., Kar, B., Choi, W. S., Lee, B. M., Bhakta, T., Atanasov, A. G., & Kim, H. S. (2019). Therapeutic value of steroidal alkaloids in cancer: Current trends and future perspectives. International Journal of Cancer, 145(7), 1731–1744. https://doi.org/10.1002/ijc.31965
  • Dholwani, K. K., Saluja, A. K., Gupta, A. R., & Shah, D. R. (2008). A review on plant-derived natural products and their analogs with anti-tumor activity. Indian Journal of Pharmacology, 40(2), 49–58. https://doi.org/10.4103/0253-7613.41038
  • Douglas, N. C., & Papaioannou, V. E. (2013). The T-box transcription factors TBX2 and TBX3 in mammary gland development and breast cancer. Journal of Mammary Gland Biology and Neoplasia, 18(2), 143–147.
  • DSD, S. J., Amgoth, C., S, S. N., CH, P., J, M., & A, K. S. (2018). Antioxidant and anticancer activities of an Aporphine alkaloid isolated from Alphonsea sclerocarp. The Journal of Phytopharmacology, 7(1), 51–55. https://doi.org/10.31254/phyto.2018.7111
  • Durant, J. L. (1996). Evaluation of transition state properties by density functional theory. Chemical Physics Letters, 256(6), 595–602.
  • Emechebe, U., Smith, R., Franklin, S., Moore, B., Yandell, M., Lessnick, S. L., & Moon, A. M. (2014). Coordinated control of senescence by lncRNA and a novel T-box3 co-repressor complex. Elife, 3, e02805.
  • Fan, W., Huang, X., Chen, C., Gray, J., & Huang, T. (2004). TBX3 and its isoform TBX3 + 2a are functionally distinctive in inhibition of senescence and are overexpressed in a subset of breast cancer cell lines. Cancer Research, 64(15), 5132–5139. https://doi.org/10.1158/0008-5472.CAN-04-0615
  • Fillmore, C. M., Gupta, P. B., Rudnick, J. A., Caballero, S., Keller, P. J., Lander, E. S., & Kuperwasser, C. (2010). Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling. Proceedings of the National Academy of Sciences, 107(50), 21737–21742.
  • Furnham, N., Holliday, G. L., de Beer, T. A., Jacobsen, J. O., Pearson, W. R., & Thornton, J. M. (2014). The Catalytic Site Atlas 2.0: cataloging catalytic sites and residues identified in enzymes. Nucleic Acids Research, 42(D1), D485–D489.
  • Guex, N., & Peitsch, M. C. (1997). Swiss PDB Viewer – References. Electrophoresis.
  • Habartová, K., Cahlíková, L., Řezáčová, M., & Havelek, R. (2016). The biological activity of alkaloids from the amaryllidaceae: From cholinesterases inhibition to anticancer activity. Natural Products Communications, 11(10), 1934578X1601101. https://doi.org/10.1177/1934578X1601101038
  • He, M. L., Wen, L., Campbell, C. E., Wu, J. Y., & Rao, Y. (1999). Transcription repression by Xenopus ET and its human ortholog TBX3, a gene involved in ulnar-mammary syndrome. Proceedings of the National Academy of Sciences of the United States of America, 96(18), 10212–10217. https://doi.org/10.1073/pnas.96.18.10212
  • Hollingsworth, S. A., & Dror, R. O. (2018). Molecular dynamics simulation for all. Neuron, 99(6), 1129–1143. https://doi.org/10.1016/j.neuron.2018.08.011
  • Irvine, J. D., Takahashi, L., Lockhart, K., Cheong, J., Tolan, J. W., Selick, H. E., & Grove, J. R. (1999). MDCK (Madin–Darby canine kidney) cells: a tool for membrane permeability screening. Journal of Pharmaceutical Sciences, 88(1), 28–33.
  • Jacobs, J. J., Keblusek, P., Robanus-Maandag, E., Kristel, P., Lingbeek, M., Nederlof, P. M., Van Welsem, T., Van De Vijver, M. J., Koh, E. Y., Daley, G. Q., & van Lohuizen, M. (2000). Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19ARF) and is amplified in a subset of human breast cancers. Nature Genetics, 26(3), 291–299.
  • Jerome-Majewska, L. A., Jenkins, G. P., Ernstoff, E., Zindy, F., Sherr, C. J., & Papaioannou, V. E. (2005). Tbx3, the ulnar-mammary syndrome gene, and Tbx2 interact in mammary gland development through a p19Arf/p53-independent pathway. Developmental Dynamics: An Official Publication of the American Association of Anatomists, 234(4), 922–933. https://doi.org/10.1002/dvdy.20575
  • Jursic, B. S. (1997). Computation of geometries and frequencies of singlet and triplet nitromethane with density functional theory using Gaussian‐type orbitals. International Journal of Quantum Chemistry, 64(2), 263–269.
  • Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., Wang, J., Yu, B., Zhang, J., & Bryant, S. H. (2016). PubChem substance and compound databases. Nucleic Acids Research, 44(D1), D1202–D1213. https://doi.org/10.1093/nar/gkv951
  • Kispert, A., & Herrmann, B. G. (1993). The Brachyury gene encodes a novel DNA binding protein. The EMBO Journal, 12(8), 3211–3220.
  • Lagorce, D., Maupetit, J., Baell, J., Sperandio, O., Tufféry, P., Miteva, M. A., Galons, H., & Villoutreix, B. O. (2011). The FAF-Drugs2 server: A multistep engine to prepare electronic chemical compound collections. Bioinformatics. Bioinformatics (Oxford, England), 27(14), 2018–2020. https://doi.org/10.1093/bioinformatics/btr333
  • Lichota, A., & Gwozdzinski, K. (2018). Anticancer activity of natural compounds from plant and marine environment. International Journal of Molecular Sciences, 19(11), 3533. https://doi.org/10.3390/ijms19113533
  • Lingbeek, M. E., Jacobs, J. J., & van Lohuizen, M. (2002). The T-box Repressors TBX2 and TBX3Specifically Regulate the Tumor Suppressor Gene p14 ARF via a Variant T-site in the Initiator. Journal of Biological Chemistry, 277(29), 26120–26127.
  • Liu, K., & Kokubo, H. (2017). Exploring the stability of ligand binding modes to proteins by molecular dynamics simulations: A cross-docking study. Journal of Chemical Information and Modeling, 57(10), 2514–2522. https://doi.org/10.1021/acs.jcim.7b00412
  • Lomnytska, M., Dubrovska, A., Hellman, U., Volodko, N., & Souchelnytskyi, S. (2006). Increased expression of cSHMT, Tbx3 and utrophin in plasma of ovarian and breast cancer patients. International Journal of Cancer, 118(2), 412–421.
  • Merscher, S., Funke, B., Epstein, J. A., Heyer, J., Puech, A., Lu, M. M., Xavier, R. J., Demay, M. B., Russell, R. G., Factor, S., Tokooya, K., Jore, B. S., Lopez, M., Pandita, R. K., Lia, M., Carrion, D., Xu, H., Schorle, H., Kobler, J. B., … Kucherlapati, R. (2001). TBX1 is responsible for cardiovascular defects in velo-cardiofacial/DiGeorge syndrome. Cell, 104(4), 619–629. https://doi.org/10.1016/S0092-8674(01)00247-1
  • Miller, K. D., Nogueira, L., Mariotto, A. B., Rowland, J. H., Yabroff, K. R., Alfano, C. M., Jemal, A., Kramer, J. L., & Siegel, R. L. (2019). Cancer treatment and survivorship statistics, 2019. CA: A Cancer Journal for Clinicians, 69(5), 363–385.
  • Mohan, K., Jeyachandran, R., & Deepa, R. (2012). Alkaloids as anticancer agents. Annels of Phytomedicine, 1(1), 46–53.
  • Naiche, L. A., Harrelson, Z., Kelly, R. G., & Papaioannou, V. E. (2005). T-box genes in vertebrate development. Annual Review of Genetics, 39(1), 219–239. https://doi.org/10.1146/annurev.genet.39.073003.105925
  • O’Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 3, 33. https://doi.org/10.1186/1758-2946-3-33
  • Opo, F. A. D. M., Rahman, M. M., Ahammad, F., Ahmed, I., Bhuiyan, M. A., & Asiri, A. M. (2021). Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein. Scientific Reports, 11(1), 4049https://doi.org/10.1038/s41598021-83626-x
  • Papaioannou, V. E. (2014). The t-box gene family: Emerging roles in development, Stem cells and cancer. Development, 141(20), 3819–3833. https://doi.org/10.1242/dev.104471
  • Parasuraman, S. (2012). Protein data bank. Journal of Pharmacology and Pharmacotherapeutics, 3(4), 351–352. https://doi.org/10.4103/0976-500X.103704
  • Pearson, R. G. (1986). Absolute electronegativity and hardness correlated with molecular orbital theory. Proceedings of the National Academy of Sciences of the United States of America, 83(22), 8440–8441. https://doi.org/10.1073/pnas.83.22.8440
  • Peres, J., Davis, E., Mowla, S., Bennett, D. C., Li, J. A., Wansleben, S., & Prince, S. (2010). The highly homologous T-Box transcription factors, TBX2 and TBX3, have distinct roles in the oncogenic process. Genes & Cancer, 1(3), 272–282.
  • Peres, J., Mowla, S., & Prince, S. (2015). The T-box transcription factor, TBX3, is a key substrate of AKT3 in melanomagenesis. Oncotarget. Oncotarget, 6(3), 1821–1833. https://doi.org/10.18632/oncotarget.2782
  • Peres, J., & Prince, S. (2013). The T-box transcription factor, TBX3, is sufficient to promote melanoma formation and invasion. Molecular Cancer, 12(1), 117 https://doi.org/10.1186/1476-4598-12-117
  • Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera-a visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/10.1002/jcc.20084
  • Prasad, K. N., Xie, H., Hao, J., Yang, B., Qiu, S., Wei, X., Chen, F., & Jiang, Y. (2010). Antioxidant and anticancer activities of 8-hydroxypsoralen isolated from wampee [Clausena lansium (Lour.) Skeels] peel. Food Chemistry, 118(1), 62–66.
  • Rodriguez, M., Aladowicz, E., Lanfrancone, L., & Goding, C. R. (2008). Tbx3 represses E-cadherin expression and enhances melanoma invasiveness. Cancer Research, 68(19), 7872–7881. https://doi.org/10.1158/0008-5472.CAN-08-0301
  • Rowley, M., Grothey, E., & Couch, F. J. (2004). The role of Tbx2 and Tbx3 in mammary development and tumorigenesis. Journal of Mammary Gland Biology and Neoplasia, 9(2), 109–118.
  • Ruvinsky, I., Silver, L. M., & Gibson-Brown, J. J. (2000). Phylogenetic analysis of T-Box genes demonstrates the importance of amphioxus for understanding evolution of the vertebrate genome. Genetics, 156(3), 1249–1257. https://doi.org/10.1093/genetics/156.3.1249
  • Sander, T., Freyss, J., Von Korff, M., Reich, J. R., & Rufener, C. (2009). OSIRIS, an entirely in-house developed drug discovery informatics system. Journal of Chemical Information and Modeling, 49(2), 232–246. https://doi.org/10.1021/ci800305f
  • Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249.
  • Thirupathi, K., Kumar, S. S., Raju, V. S., Ravikumar, B., Krishna, D. R., & Mohan, G. K. (2008). A review of medicinal plants of the genus Cordia: Their chemistry and pharmacological uses. Journal of Natural Remedies, 8(1), 1–10.
  • Trott, O., & Olson, A. J. (2010). AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461.
  • Van Breemen, R. B., & Li, Y. (2005). Caco-2 cell permeability assays to measure drug absorption. Expert Opinion on Drug Metabolism & Toxicology, 1(2), 175–185. https://doi.org/10.1517/17425255.1.2.175
  • Viana Nunes, A. M., das Chagas Pereira de Andrade, F., Filgueiras, L. A., de Carvalho Maia, O. A., Cunha, R. L. O. R., Rodezno, S. V. A., Maia Filho, A. L. M., de Amorim Carvalho, F. A., Braz, D. C., & Mendes, A. N. (2020). preADMET analysis and clinical aspects of dogs treated with the Organotellurium compound RF07: A possible control for canine visceral leishmaniasis? Environmental Toxicology and Pharmacology, 80, 103470. https://doi.org/10.1016/j.etap.2020.103470
  • Visualizer, D. S. (2020). BIOVIA Work. Release. Biovia. Dassault Systèmes.
  • Willmer, T., Cooper, A., Peres, J., Omar, R., & Prince, S. (2017). The T-Box transcription factor 3 in development and cancer. BioScience Trends, 11(3), 254–266. https://doi.org/10.5582/bst.2017.01043
  • Willmer, T., Peres, J., Mowla, S., Abrahams, A., & Prince, S. (2015). The T-box factor TBX3 is important in S-phase and is regulated by c-MYC and cyclin A-CDK2. Cell Cycle (Georgetown, Tex), 14(19), 3173–3183. https://doi.org/10.1080/15384101.2015.1080398
  • Wilson, V., & Conlon, F. L. (2002). The T-box family. Genome Biology, 3(6), REVIEWS3008. https://doi.org/10.1186/gb-20023-6-reviews3008
  • Wu, G. J., Sinclair, C., Hinson, S., Ingle, J. N., Roche, P. C., & Couch, F. J. (2001). Structural analysis of the 17q22–23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumors. Cancer Research, 61(13), 4951–4955.
  • Yadav, A., & Mohite, S. (2020). ADME analysis of phytochemical constituents of Psidium guajava. Asian Journal of Chemistry, 13(5), 373–375.
  • Yarosh, W., Barrientos, T., Esmailpour, T., Lin, L., Carpenter, P. M., Osann, K., Anton-Culver, H., & Huang, T. (2008). TBX3 is overexpressed in breast cancer and represses p14ARF by interacting with histone deacetylases. Cancer Research, 68(3), 693–699. https://doi.org/10.1158/0008-5472.CAN-07-5012
  • Yi Li, Q., Newbury-Ecob, R. A., Terrett, J. A., Wilson, D. I., Curtis, A. R., Ho Yi, C., Gebuhr, T., Bullen, P. J., Robson, S. C., Strachan, T., Bonnet, D., Lyonnet, S., Young, I. D., Alexander Raeburn, J., Buckler, A. J., Law, D. J., & Brook, J. D. (1997). Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nature Genetics, 15(1), 21–29.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.